Review decisions

Showing 10 results of 281 total
Summary Safety Review - Neulasta (pegfilgrastim) - Assessing the Potential Risks of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1712840271387
DIN(s): 02249790, 02474565, 02484153, 02497395, 02506238, 02529343
Issued / Original Publication Date: 2024-04-19
Updated Date: 2024-04-19
Summary Safety Review - Ibrance (palbociclib) - Assessing the Potential Risk of Venous Thromboembolism
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1707157428464
DIN(s): 02453150, 02453169, 02453177, 02493535, 02493543, 02493551
Issued / Original Publication Date: 2024-02-09
Updated Date: 2024-02-09
Summary Safety Review - Amiodarone - Assessing the Potential Risk of Primary Graft Dysfunction Following Heart Transplantation
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1706035839788
DIN(s): 02239835, 02242325, 02242472, 02243836, 02245248, 02246194, 02246331, 02247217, 02249502, 02292173, 02294508, 02309661, 02364336, 02385465, 02423227, 02427346, 02531844
Issued / Original Publication Date: 2024-02-01
Updated Date: 2024-02-01
Summary Safety Review - Colistin (colistimethate sodium) - Assessing the Potential Risk of Pseudo-Bartter Syndrome
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1705515920269
DIN(s): 00476420, 02244849, 02403544
Issued / Original Publication Date: 2024-01-18
Updated Date: 2024-01-18
Summary Safety Review - Dimethyl Fumarate - Assessing the Potential Risk of Fanconi Syndrome
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1697629380576
DIN(s): 02404508, 02420201, 02493586, 02493594, 02494809, 02494817, 02495341, 02495368, 02497026, 02497034, 02502690, 02502704, 02505762, 02505770, 02513781, 02513803, 02515563, 02515571, 02516047, 02516055, 02540746, 02540754
Issued / Original Publication Date: 2023-10-27
Updated Date: 2023-10-27
Summary Safety Review - Domperidone - Assessing the Potential Risk of Psychiatric Withdrawal Events when Used for Lactation Stimulation
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1691692252806
DIN(s): 01912070, 02103613, 02236466, 02236857, 02238341, 02268078, 02350440, 02369206, 02403218, 02403870, 02408937, 02445034, 02462834
Issued / Original Publication Date: 2023-08-30
Updated Date: 2023-08-30
Summary Safety Review - Keytruda (pembrolizumab) and Tecentriq (atezolizumab) - Assessing the Potential Risk of Aplastic Anemia
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1691503886633
DIN(s): 02456869, 02462990, 02468816, 02469723, 02487144, 02487152, 02492393, 02523434
Issued / Original Publication Date: 2023-08-17
Updated Date: 2023-08-17
Summary Safety Review - Tagrisso (osimertinib) - Assessing the Potential Risk of Rhabdomyolysis and Other Myopathy-related Events
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1690380271165
Product Type: Drug
DIN(s): 02456214, 02456222
Issued / Original Publication Date: 2023-07-26
Updated Date: 2023-07-26
Summary Safety Review - Soliris (eculizumab) - Assessing the Potential Risk of Drug-induced Liver Injury
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1685124881584
DIN(s): 02322285
Issued / Original Publication Date: 2023-06-07
Updated Date: 2023-06-07
Summary Safety Review - Combination Sulfamethoxazole and Trimethoprim - Assessing the Potential Risk of Hemophagocytic Lymphohistiocytosis
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1683728246915
DIN(s): 00445266, 00445274, 00445282, 00510637, 00510645, 00550086, 00726540, 00846465, 02525917, 02530023, 02534746
Issued / Original Publication Date: 2023-05-24
Updated Date: 2023-05-24

Displaying 1 - 10 of 281 | Page 1 of 29
Report a problem or mistake on this page
Please select all that apply:
Date modified: